Saypha Volume Plus Lidocaine

Saypha Volume Plus Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, designed to correct moderate to severe midface volume deficit. Intended for qualified practitioners, it must be administered by deep subcutaneous and/or supraperiosteal injection. Its cross-linked hyaluronic acid, obtained from Streptococcus equi bacteria, is supplemented with lidocaine hydrochloride and phosphate buffered, providing 2.5% sodium hyaluronate (equivalent to 25 mg/mL), lidocaine HCl 0.3% and BDDE at 2 ppm or less, for professional use. Each box contains one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

• Corrects moderate to severe midface volume deficit
• Cross-linked sodium hyaluronate at 25 mg/mL, the highest concentration in the Saypha range
• Of non-animal origin, obtained from Streptococcus equi bacteria
• Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
• BDDE cross-linking agent present at 2 ppm or less
• Steam sterilised in the syringe, which serves as the sterile barrier
• Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
• Manufactured by Croma-Pharma in Austria

Wskazania i zastosowanie profesjonalne

Główne wskazania

• Moderate to severe midface volume deficit

Zastosowanie profesjonalne

Saypha Volume Plus Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is administered by deep subcutaneous and/or supraperiosteal injection, which demands advanced anatomical knowledge of the midface. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered, and the concomitant use of other local anaesthetics or agents structurally related to amide-type anaesthetics should also be taken into account since systemic toxicity may be additive.

Obszary zabiegowe

• Midface, by deep subcutaneous and/or supraperiosteal injection

Profil pacjenta

For adults 18 years of age or older, assessed as suitable by the treating practitioner, typically those presenting with midface volume deficit rather than a surface line to correct. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

Jak działa Saypha Volume Plus Lidocaine ​

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty SAYPHA od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z certyfikatem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z dedykowanym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania